Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WV/Huntington
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Huntington, WV

Studies commonly pay $75 to $4,500 per completed study

55 clinical trials are currently recruiting participants within 30 miles of Huntington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

55studies recruiting
4+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Huntington right now

Top 25 of 55 recruiting studies, sorted by proximity — each links to its official registry page

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: SWOG Cancer Research Network

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
Local Institution - Unk064 — Huntington, West Virginia (0.8 mi) · Sponsor: Mirati Therapeutics Inc.

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

Lung Cancer Screening N/A Interventional 330 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi) · Sponsor: Timothy Mullett

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

Chronic Migraine in Children Phase 3 Interventional 285 participants sought
Marshall Health-Marshall University Medical Center — Huntington, West Virginia (0.8 mi) · Sponsor: H. Lundbeck A/S

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Glioblastoma, IDH-Wildtype Phase 2 Interventional 100 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Hepatitis Phase 3 Interventional 350 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: Bausch Health Americas, Inc.

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Phase 2 Interventional 146 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Systolic Hypertension, Pregnancy Related N/A Observational 60 participants sought
Maternal Hypertension Center at Cabell Huntington Hospital — Huntington, West Virginia (0.8 mi) · Sponsor: Marshall University

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Neoplasms, Arteriovenous Malformation of Central Nervous System N/A Observational 50,000 participants sought
St. Mary's Medical Center — Huntington, West Virginia (0.8 mi) · Sponsor: The Radiosurgery Society

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Anterior Cruciate Ligament Rupture N/A Observational 450 participants sought
Marshall University — Huntington, West Virginia (0.8 mi) · Sponsor: Marshall University

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 56 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: SWOG Cancer Research Network

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 Phase 2 Interventional 2,900 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention

Lung Cancer Screening N/A Interventional 35,500 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi) · Sponsor: Timothy Mullett

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 66 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: SWOG Cancer Research Network

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Multiple conditions Phase 3 Interventional 1,780 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi) · Sponsor: NRG Oncology
Actively enrolling

Studies you may be able to join near Huntington

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Huntington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Research Systems

★ 3.5
7 Stonecrest Dr, Huntington, WV 25701
(304) 529-4453
"Had a great experience getting a drug screening at Health Research Systems in Huntington, WV. The staff was courteous, efficient, and kept everything…"
— Gabriels Travel Secrets, 5★

Marshall University Joan C. Edwards School of Medicine

★ 4.8
1600 Medical Center Dr, Huntington, WV 25701
(304) 691-1700
"Wonderful campus, friendly staff, and delightful students"
— Sunny “SUNNY” Sturgell- Morris, 5★

Marshall Health

★ 2.3
1600 Medical Center Dr, Huntington, WV 25701
(304) 691-1600

CAMC Clinical Trials Center

★ 5.0
3100 MacCorkle Ave SE #806, Charleston, WV 25304
(304) 388-9944

Clinical trials in Huntington: what's recruiting

The Huntington area currently has 55 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Huntington, the most active research areas are:

  • Cancer & Oncology19 studies
  • Liver & Kidney3 studies
  • Brain & Mental Health1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Huntington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Huntington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Huntington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Huntington pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Huntington?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Huntington safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Huntington?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Huntington.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Huntington typically complete one or two studies per year.

Paid clinical trials near Huntington

Other metros within reach

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts